ORSINI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.662
EU - Europa 616
AS - Asia 263
AF - Africa 2
OC - Oceania 1
SA - Sud America 1
Totale 2.545
Nazione #
US - Stati Uniti d'America 1.657
DE - Germania 223
CN - Cina 163
SE - Svezia 107
IT - Italia 79
SG - Singapore 69
GB - Regno Unito 53
RU - Federazione Russa 41
FI - Finlandia 40
FR - Francia 34
BE - Belgio 16
VN - Vietnam 14
IN - India 9
CZ - Repubblica Ceca 7
IE - Irlanda 6
CA - Canada 4
IR - Iran 3
HK - Hong Kong 2
KR - Corea 2
LT - Lituania 2
PL - Polonia 2
UA - Ucraina 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
HR - Croazia 1
JP - Giappone 1
MA - Marocco 1
MX - Messico 1
NA - Namibia 1
NL - Olanda 1
RO - Romania 1
Totale 2.545
Città #
Fairfield 267
Chandler 204
Woodbridge 145
Ashburn 136
Houston 115
Seattle 103
Cambridge 96
Nyköping 92
Wilmington 73
Ann Arbor 70
New York 59
Singapore 56
Beijing 50
Bari 34
Munich 29
Lawrence 25
Roxbury 25
Helsinki 24
Nanjing 22
Brooklyn 21
Marseille 18
Brussels 16
Des Moines 16
Redwood City 15
Dong Ket 14
San Diego 13
Jacksonville 11
Los Angeles 10
Nanchang 9
Paris 9
Guangzhou 8
Hebei 7
London 7
Princeton 7
Boardman 6
Dublin 6
Changsha 5
Tianjin 5
Brno 4
Falls Church 4
Jiaxing 4
Santa Clara 4
Shenyang 4
Espoo 3
Inglewood 3
Jinan 3
Pune 3
Shanghai 3
Wuhan 3
Brindisi 2
Dearborn 2
Frankfurt am Main 2
Hong Kong 2
Indiana 2
Kilburn 2
Milan 2
New Delhi 2
Olomouc 2
Ottawa 2
Padova 2
Pulsano 2
San Mateo 2
Terni 2
Tiantai Chengguanzhen 2
Toronto 2
Zhengzhou 2
Avigliano 1
Birmingham 1
Böblingen 1
Clifton 1
Corato 1
Daejeon 1
Duncan 1
Fuzhou 1
Hefei 1
Heze 1
Kraków 1
Leawood 1
Mashhad 1
Melbourne 1
Miami 1
Monterrey 1
Naples 1
Ningbo 1
Norwalk 1
Omsk 1
Perugia 1
Piano Di Sorrento 1
Prague 1
Quzhou 1
San Francisco 1
Secunderabad 1
Seoul 1
Tappahannock 1
Tokyo 1
Torino 1
Torregrotta 1
Warsaw 1
Washington 1
Weifang 1
Totale 1.934
Nome #
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 167
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 137
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 137
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 132
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 128
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 121
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 117
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 116
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 114
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 111
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 102
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 100
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 97
null 94
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 91
null 87
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 76
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 73
null 73
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 71
Droplet Digital PCR Analysis for Diagnosis and Minimal Residual Disease Monitoring in Adult Ph plus Acute Lymphoblastic Leukemia 70
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 60
null 58
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 44
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities 38
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia 33
Genetic Pattern, Orthodontic and Surgical Management of Multiple Supplementary Impacted Teeth in a Rare, Cleidocranial Dysplasia Patient: A Case Report 31
null 29
Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement 28
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms 27
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia 25
Systemic Mastocytosis With Associated Chronic Lymphocytic Leukemia: A Matter Of Diseases Or Prognostic Factors 20
Horizontal Gaze Palsy with Progressive Scoliosis with Overlapping Epilepsy and Learning Difficulties: A Case Report 14
A Rare Case of Concurrent 2q34q36 Duplication and 2q37 Deletion in a Neonate with Syndromic Features 9
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition? 7
Nanopore sequencing sheds a light on the FLT3 gene mutations complexity in acute promyelocytic leukemia 6
The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis 6
Totale 2.649
Categoria #
all - tutte 10.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020410 0 0 0 0 54 44 43 58 70 64 38 39
2020/2021396 14 70 18 39 38 28 15 68 12 36 27 31
2021/2022235 22 19 6 6 5 30 9 8 17 23 33 57
2022/2023461 43 78 27 34 55 55 4 56 81 5 9 14
2023/2024227 12 29 8 14 22 85 2 9 1 7 6 32
2024/2025206 51 13 34 76 32 0 0 0 0 0 0 0
Totale 2.649